Georgia Appellate Court Orders New Trial in J&J Talc Baby Powder Cancer Wrongful Death Case
If you are reading this page, someone you love used talcum powder for years — maybe decades — and then developed cancer, and now you are trying to understand what a court ruling out of Georgia means for your family. Maybe you heard about this decision and wondered whether it opens a door. Maybe you are sitting at a kitchen table at 2 a.m. with a death certificate and a bathroom cabinet that still has a bottle of baby powder in it, and you are trying to figure out whether anyone can be held accountable.
We are going to tell you exactly what this ruling means, what it does not mean, and what it changes for families in Georgia who lost someone to cancer after long-term use of talc-based products. This page is legal information, not legal advice. Contacting our firm is free and confidential, and we do not get paid unless we win your case. Call us at 1-888-ATTY-911, any hour, any day.
What the Georgia Appellate Panel Actually Decided
A Georgia appellate panel affirmed a trial judge’s order granting a new trial in a wrongful death lawsuit alleging that Johnson & Johnson’s talc-based baby powder caused a woman’s fatal cancer. The panel agreed with the trial judge that the original defense verdict — meaning the jury’s decision in favor of J&J — was not supported by sufficient evidence.
Here is what that sentence means in plain English: a jury had ruled for Johnson & Johnson, and the judge looked at that verdict and said, in effect, “the evidence J&J presented does not legally support this result.” The Georgia Court of Appeals agreed. The case will be retried. The family gets another chance in front of a new jury.
This is not the same as saying the family won. The appellate court did not rule that talc caused the cancer, did not rule that J&J is liable, and did not order J&J to pay anything. What the court ruled is narrower and more specific — but still powerful: the defense’s evidentiary presentation was legally inadequate to sustain a verdict in J&J’s favor. That finding has teeth, and we will explain exactly what those teeth are when we discuss retrial strategy below.
If your family is facing the same kind of loss — a mother, a wife, a sister who used talc-based baby powder for years and then developed ovarian cancer or another cancer linked to talc exposure — this ruling matters to you. Not because it guarantees anything, but because it signals that Georgia’s appellate courts are willing to scrutinize defense verdicts in talc cases and require the defense to actually prove its case, not just walk into court and point at the general scientific debate.
The National Landscape: Tens of Thousands of Talc Cases Against J&J
This Georgia case does not exist in isolation. As of mid-2026, more than 68,000 talc-related claims are pending against Johnson & Johnson in a consolidated federal proceeding — MDL-2738, the In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, before Judge Michael A. Shipp in the District of New Jersey. That number — 68,029 actions pending as of the June 2026 JPML report — tells you something about the scale of the problem. This is not a handful of plaintiffs. This is a mass of families who believe a product they trusted for decades caused a disease that killed someone they loved.
The outcomes across these cases have varied widely. Some juries have returned massive verdicts for plaintiffs. Others, like the Georgia jury in this case before the new trial was ordered, ruled for the defense. The inconsistency is not evidence that the claims are baseless — it is evidence that the science is contested, that the defense is well-funded and aggressive, and that the outcome in any single trial depends heavily on the quality of the expert testimony, the strength of the specific-causation evidence, and the venue.
One verdict that survived appeal is worth knowing about: in Ingham v. Johnson & Johnson, a Missouri jury returned a $4.69 billion verdict for 22 women who alleged talc caused their ovarian cancer. The Missouri Court of Appeals reduced that to approximately $2.12 billion in June 2020. The Missouri Supreme Court declined to review the reduction. And on June 1, 2021, the United States Supreme Court denied certiorari — meaning the reduced verdict stands as a final, affirmed judgment. That is a real number, upheld through the highest court in the country’s refusal to disturb it. But it came from 22 plaintiffs in Missouri, not one plaintiff in Georgia, and Georgia juries have historically been more measured than Missouri or California juries on damages awards. We mention it not to promise a similar result, but to show you that these cases can be won — and that when they are won, the numbers can be enormous.
Past results depend on the facts of each case and do not guarantee future outcomes.
Who Johnson & Johnson Really Is: The Corporate Structure Behind the Powder
Johnson & Johnson is one of the largest pharmaceutical and consumer-product companies in the world. But when you sue J&J over talc, the name on the courthouse door is rarely “Johnson & Johnson” alone. The corporate structure has been deliberately engineered — through spinoffs, divisional mergers, and bankruptcy vehicles — to complicate the question of who is responsible and who pays.
The historical seller of the talc-based baby powder was Johnson & Johnson Consumer Inc., sometimes called JJCI. In 2023, J&J spun off its consumer health division into a separate publicly traded company called Kenvue Inc. — which now owns brands like Band-Aid, Tylenol, and Listerine. Kenvue took the consumer-product brand with it, but J&J retained indemnity obligations for talc liability under the separation agreement. The corporate family keeps moving.
Then there is the bankruptcy maneuver — what lawyers call the “Texas two-step.” J&J created a subsidiary called LTL Management LLC to hold the talc liability, then pushed that entity into Chapter 11 bankruptcy to try to force a global settlement that would have capped J&J’s exposure and channeled all claims into a trust. A federal bankruptcy court dismissed that filing. J&J tried again with a renamed entity, Red River Talc LLC. On March 31, 2025, the U.S. Bankruptcy Court for the Southern District of Texas denied confirmation and dismissed Red River Talc’s prepackaged Chapter 11 — J&J’s third failed bankruptcy attempt. The court found vote-solicitation irregularities and impermissible nonconsensual third-party releases.
Three times J&J tried to wall these cases off inside a bankruptcy it created on purpose. Three times a court threw it out. The cases are back in the tort system — which means they are being fought in courthouses, one at a time, including in Georgia.
Why does this matter to you? Because the entity you sue, and the entity that ultimately pays, may not be the name on the bottle. A toxic tort claim lawyer who understands corporate structure can identify every entity in the chain — the parent, the historical seller, the spinoff, the indemnitor — and make sure no deep pocket escapes the caption of your lawsuit. Naming the wrong entity, or naming only the obvious one, is a mistake that can shrink a case from seven figures to nothing.
Georgia Product Liability Law: The Tools That Make This Case Different
Georgia’s legal framework for product liability cases gives families tools that some other states do not. Understanding these tools — and how they differ from what you might have heard about cases in other states — is essential to evaluating what a talc cancer wrongful death case is worth in Georgia.
Georgia’s wrongful death statute provides for recovery of the “full value of the life” of the decedent — encompassing both the economic value (lost earnings, benefits, household services) and the intangible value (the decedent’s enjoyment of life and relationships). This is a powerful doctrine. It means Georgia law recognizes that a human life has value beyond the paychecks it produces — the joy of living, the relationships, the daily experience of being a person in the world — and allows a jury to put a dollar figure on that value.
A separate survival action may capture the decedent’s conscious pain and suffering, mental anguish, and medical expenses between the cancer diagnosis and death. The wrongful death claim belongs to the family; the survival claim belongs to the estate. Both can be pursued together, and a complete case uses both.
Georgia’s comparative negligence rule follows a modified standard with a 50 percent bar. This means a plaintiff is barred from recovery only if assigned 50 percent or more of the fault. If the plaintiff is found 49 percent at fault, recovery is reduced by that percentage but not eliminated. In a talc case, the defense may try to assign fault to the decedent for choosing to use the product — but that argument is weak when the product was marketed as safe for daily use and no cancer warning was ever provided.
Georgia’s punitive damages statute is where this case type gets its teeth. Georgia generally caps punitive damages, but it expressly exempts product liability actions from that cap. This exemption is a significant value driver in a talc cancer case, because the public record of internal J&J documents — produced in nationwide talc litigation — includes evidence suggesting awareness of asbestos contamination in certain talc lots and knowledge of epidemiological studies linking perineal talc use to ovarian cancer. If a jury finds that J&J knew of the risk and chose not to warn consumers, that is the punitive damages predicate: willful misconduct, wantonness, or reckless disregard for consumer safety. And in Georgia, unlike many states, there is no statutory ceiling on what that punishment can be.
Georgia adopted the Daubert standard for expert witness admissibility, which governs the critical causation testimony that is the battleground in every talc case. Under Daubert, the trial judge serves as a gatekeeper, evaluating whether expert testimony is based on reliable scientific methodology before it reaches the jury. In a talc case, both sides bring experts — epidemiologists, toxicologists, gynecologic oncologists, pathologists — and the Daubert hearing can decide the case before the jury ever hears a word. If the plaintiff’s general-causation expert is excluded, the case may be impossible to prove. If the defense’s experts are limited or excluded — which is effectively what happened when the appellate court found the defense verdict “not supported by sufficient evidence” — the defense’s case shrinks.
Georgia’s statute of limitations for wrongful death is generally two years from the date of death. However, the discovery rule may affect accrual in toxic exposure cases — meaning the clock may not start running until the family knew or reasonably should have known that the cancer was connected to talc use. This is a critical question for any family considering a claim, and the specific accrual rule should be confirmed with a Georgia attorney for your particular facts. Do not assume the deadline has passed without checking.
What “Insufficient Evidence” Means for Retrial Strategy
The appellate court’s finding that the defense verdict was “not supported by sufficient evidence” is a specific legal ruling with specific consequences. It does not mean the defense presented no evidence. It means the evidence the defense presented, viewed in the light most favorable to the verdict, was legally inadequate to sustain it.
This distinction matters enormously for retrial. On retrial, plaintiff’s counsel can leverage the appellate ruling to frame the defense’s causation rebuttal as previously adjudicated as legally inadequate — not merely unpersuasive to one jury, but judicially determined to fall short of what the law requires. In opening statement, a skilled trial attorney can tell the new jury that an appellate court of this state has already ruled that the evidence J&J presented to defend itself was insufficient. That is not a closing argument flourish — it is a fact entered into the record by a panel of judges.
The retrial also gives the plaintiff’s estate an opportunity to present causation evidence with the benefit of hindsight — knowing exactly which defense arguments the first jury found compelling and which fell short. Expert selection becomes paramount. A board-certified gynecologic oncologist or cancer epidemiologist should anchor general causation — the proposition that talc exposure in the perineal region can cause ovarian cancer. A forensic pathologist or toxicologist with exposure-reconstruction expertise should bridge to specific causation — the proposition that talc exposure caused THIS decedent’s cancer, given her usage history, tumor characteristics, and the exclusion of alternative causes.
Voir dire in the retrial should probe jurors’ attitudes about corporate accountability, personal-care product safety assumptions, and the distinction between FDA regulatory silence and actual product safety. Many jurors assume that if a product is sold on store shelves for decades, the government must have deemed it safe. That assumption is wrong — and explaining why it is wrong is central to the case.
The Regulatory Gap: Why FDA Silence Is Not Safety
The FDA regulates cosmetic products under the Federal Food, Drug, and Cosmetic Act. But the regulatory framework for cosmetics is fundamentally different from the framework for drugs and medical devices. The FDA does not require pre-market approval for cosmetics. It does not require specific safety testing before a cosmetic product goes on store shelves. And it has never mandated cancer warnings on talc-based cosmetic products, despite decades of scientific debate about the association between perineal talc use and ovarian cancer.
The FDA has conducted testing and issued advisories regarding potential asbestos contamination in cosmetic talc products. Asbestos is classified by the International Agency for Research on Cancer as a Group 1 known human carcinogen — the highest hazard category, reserved for substances proven to cause cancer in people. Talc and asbestos are geologically related minerals that are often found together in the same mines, which is why asbestos contamination of cosmetic talc has been documented in testing by independent laboratories and government agencies.
But here is the critical point for your case: the absence of a specific FDA warning does not establish product safety, and it does not shield a manufacturer from state-law failure-to-warn claims. Regulatory silence is not a regulatory endorsement. The FDA’s decision not to require a cancer warning on talc-based powder does not mean the agency studied the question and concluded talc is safe. It may mean the agency has not yet acted, or that its regulatory authority over cosmetics is limited, or that the political and procedural hurdles to requiring a warning have not been cleared.
The absence of a specific FDA warning does not establish product safety or shield a manufacturer from state-law failure-to-warn claims, as regulatory silence is not a regulatory endorsement of safety.
Johnson & Johnson will argue in every talc case that it complied with all FDA requirements. That argument is designed to make jurors think the government blessed the product. The truth is closer to this: the government never required J&J to prove its talc was safe before selling it, never required J&J to test for asbestos contamination on an ongoing basis, and never required J&J to warn consumers about cancer risk. Compliance with a regulatory floor that never asked the safety question is not the same as a safe product.
This is exactly the kind of distinction a generalist lawyer misses — and it is the kind of distinction that can change a jury’s understanding of who is responsible.
The Medicine: How Talc Exposure Becomes Fatal Cancer
The medical battle in every talc case is fought on two fronts: general causation and specific causation. General causation asks whether talc exposure can cause the type of cancer the decedent developed. Specific causation asks whether talc exposure did cause this particular person’s cancer. Both must be proven, and the defense fights on both.
General causation — the scientific landscape. The epidemiological literature on perineal talc use and ovarian cancer spans decades. Multiple case-control studies and cohort studies have reported elevated odds ratios — meaning women who used talc in the perineal region had higher rates of ovarian cancer than women who did not. The defense points to studies that found no statistically significant association and argues the evidence is inconsistent. The plaintiff’s experts synthesize the body of literature and argue that the weight of the evidence supports a causal connection, particularly for serous ovarian cancer, the most common subtype.
There is also the asbestos-contamination pathway. If talc is contaminated with asbestos — and testing has shown that some cosmetic talc products contained detectable amounts of asbestos fibers — then the causal mechanism shifts from talc particles themselves to asbestos, a proven Group 1 human carcinogen. Asbestos causes mesothelioma, a cancer of the lining of the lungs and abdomen, but it has also been associated with ovarian cancer. The presence of asbestos in talc creates a second causal pathway that the defense must rebut.
Specific causation — the individual bridge. Specific causation is where the case becomes personal. The expert must connect the general science to this decedent’s specific exposure history and tumor characteristics. This requires:
-
Dose reconstruction: How much talc did the decedent use? How often? For how many years? What brand? This evidence comes from family testimony, purchase records, and household inventory — and it is the most perishable evidence in the case. Family memories fade. Surviving witnesses age. No appellate ruling can regenerate a sister’s memory of how her mother applied baby powder every morning after her shower for thirty years.
-
Exposure route: The talc was applied in the perineal region — the area between the vagina and the anus. This is the exposure route that the epidemiological studies specifically identified as associated with elevated ovarian cancer risk. The mechanism is thought to involve talc particles (or asbestos fibers, if contaminated) traveling through the reproductive tract to the ovaries, where chronic inflammation and cellular damage may initiate malignant transformation.
-
Differential diagnosis: The expert must rule out alternative causes. Ovarian cancer has multiple known risk factors — genetic predisposition (BRCA1/BRCA2 mutations), family history, age, reproductive history, hormone use, obesity. The defense will argue that the decedent’s cancer was caused by one of these factors, not talc. The plaintiff’s expert conducts a differential diagnosis: identifying all plausible causes, evaluating the evidence for each, and concluding that talc exposure is the most likely cause to a reasonable degree of medical probability.
Latency. Cancer develops over years — often decades. The latency period between the start of talc exposure and the diagnosis of ovarian cancer can be 15 to 30 years or more. This long latency is why the discovery rule matters for statute-of-limitations purposes, and it is also why the defense tries to exploit the passage of time: memories fade, products are discontinued, packaging changes, and the specific lot numbers of powder the decedent used decades ago are impossible to identify. The defense counts on time erasing the proof.
The proof problem the defense exploits. The defense has three main attacks: (1) the science is not settled — general causation is not proven; (2) even if talc can cause cancer, this particular cancer had other causes — specific causation is speculative; and (3) the decedent’s own choices contributed to her disease. The first attack is met with the weight of the epidemiological literature and expert synthesis. The second is met with a thorough differential diagnosis that eliminates alternative causes. The third is met with the fact that the product was marketed as safe for daily use — the decedent had no reason to believe she was exposing herself to cancer risk, and the law does not expect consumers to independently research the carcinogenicity of products that a multibillion-dollar company markets as gentle enough for babies.
What Your Case Is Worth: Georgia’s Damages Framework
The value of a talc cancer wrongful death case in Georgia is driven by several interacting factors: the strength of the causation evidence, the age and earning capacity of the decedent, the extent of conscious pain and suffering before death, the presence of evidence supporting punitive damages, and the venue.
Based on the case characteristics in this Georgia ruling — a wrongful death from cancer allegedly caused by prolonged talc use, with the appellate court’s finding that the defense evidence was insufficient — the case value range we would expect is:
Low end: approximately $5 million. This assumes a strong compensatory case but a weak punitive predicate — no internal documents showing J&J knew of the specific risk to this decedent, no evidence of conscious corporate concealment, and a venue that tends toward conservative damages awards. The compensatory figure includes the full value of the life (economic and intangible), funeral expenses, and the survival claim for conscious pain and suffering between diagnosis and death.
High end: $75 million or more. This assumes a strong punitive predicate — internal J&J documents showing awareness of cancer risk studies and potential asbestos contamination, evidence that the company chose not to warn consumers despite that knowledge, and a venue receptive to corporate-accountability narratives. Georgia’s uncapped punitive damages in product liability cases is the engine that drives this upside. A jury that is angered by evidence of corporate concealment can return a punitive award that dwarfs the compensatory figure.
The principal deflator is the ongoing scientific debate over general causation. If the defense successfully excludes the plaintiff’s general-causation expert at the Daubert hearing — or limits the expert’s testimony to the point where the jury is left uncertain whether talc can cause cancer at all — the case value collapses. This is why expert selection and Daubert preparation are the most important strategic decisions in any talc case.
The Ingham verdict in Missouri — $2.12 billion affirmed, cert denied — is a national comparable, but it involved 22 plaintiffs, not one, and it came from a venue known for large verdicts. Georgia jurors tend to be more measured. A single-plaintiff wrongful death case in Georgia, even with a strong punitive predicate, would likely produce a smaller number than Ingham. But the combination of Georgia’s uncapped punitive damages in product liability and the documented pattern of internal J&J knowledge creates real, substantial upside.
We handle these cases on contingency. The fee is 33.33 percent before trial and 40 percent if the case goes to trial. We do not get paid unless we win your case. The first conversation costs nothing.
The Defense Playbook: What J&J Will Try on Retrial
Johnson & Johnson does not settle talc cases easily. The company has historically preferred to try them — betting that the scientific complexity, the latency issues, and the cost of litigation will wear down plaintiffs and their lawyers. Knowing the defense playbook in advance is how you prepare for it.
Play 1: The general-causation assault. J&J will bring epidemiologists and biostatisticians to testify that the scientific evidence does not establish that talc causes ovarian cancer. They will cite studies that found no statistically significant association, argue that the studies that did find an association were methodologically flawed, and frame the entire body of literature as inconclusive. Counter: The plaintiff’s expert synthesizes the full weight of the evidence, explains why some studies found associations and others did not, and identifies the biological mechanism — chronic inflammation from talc particles in the reproductive tract — that supports a causal inference. The appellate ruling that the defense evidence was insufficient is itself a weapon here: it tells the retrial jury that the defense’s previous attempt to minimize the science was adjudicated as legally inadequate.
Play 2: The alternative-cause pivot. J&J will argue that the decedent’s cancer was caused by something else — genetics, BRCA mutations, reproductive history, hormone therapy, age, obesity, or simply bad luck. The defense will bring a gynecologic oncologist to testify that most ovarian cancer is “idiopathic” — meaning it has no identifiable cause — and that attributing this particular cancer to talc is speculative. Counter: A rigorous differential diagnosis that evaluates every known risk factor, documents which were present and which were absent in this decedent, and concludes that talc exposure is the most likely cause to a reasonable degree of medical probability. The absence of a BRCA mutation, the absence of a family history, the presence of decades of perineal talc use — these facts build the bridge from general to specific causation.
Play 3: The regulatory-compliance defense. J&J will point to the FDA’s failure to require a cancer warning on talc-based products and argue that the company complied with all applicable regulations. The implication is: if the product were dangerous, the government would have said so. Counter: The FDA’s regulatory framework for cosmetics does not require pre-market safety testing, does not require pre-market approval, and does not mandate cancer warnings. The agency’s silence is a function of its limited authority over cosmetics, not a scientific conclusion that talc is safe. A manufacturer’s duty to warn under Georgia law is independent of FDA action — the company is responsible for warning about known risks regardless of whether the government requires it.
Play 4: The statute-of-limitations attack. J&J may argue that the claim was filed too late — that the family knew or should have known about the connection between talc and cancer before the two-year wrongful death deadline expired. Counter: The discovery rule in toxic exposure cases means the clock may not start until the family knew or reasonably should have known that the cancer was caused by talc. For many families, that connection was never made until after the death — and sometimes not until a lawyer or a news story identified the link. The specific accrual rule varies, and this is a question that must be evaluated by a Georgia attorney for your specific facts.
Play 5: The bankruptcy maneuver. J&J has tried three times to push talc liability into a bankruptcy vehicle to force a global settlement. All three attempts failed. But the company may try again — and if it does, the strategy is designed to freeze litigation, channel claims into a trust, and cap the company’s exposure. Counter: Monitor for any new bankruptcy filing and be prepared to argue that the maneuver is an abuse of the bankruptcy system designed to escape jury trials. The track record of dismissals — including the March 2025 dismissal of Red River Talc’s Chapter 11 — is powerful evidence that courts are not willing to let J&J use bankruptcy to avoid accountability.
The Evidence Clock: What Exists, Who Holds It, How Fast It Dies
Every talc cancer case lives or dies on evidence that is eroding right now, even as you read this. Some of that evidence is on a clock so short that the day you call a lawyer is the day the clock starts working for you instead of against you.
High urgency — decedent’s product usage history. This is the specific-causation foundation, and it is the most perishable evidence in the entire case. Receipts, household inventory, and — above all — family testimony regarding the frequency, duration, and manner of talc application. How often did she use it? Every day after showering? After every bathroom visit? For how many years? What brand? Did she apply it directly to the perineal area? Who else in the household would have observed this routine? This evidence exists only in the memories of people who knew her daily routines — and those memories fade with every passing month. Surviving witnesses age. Siblings die. Children forget the specifics. No appellate ruling, no court order, no discovery request can regenerate a daughter’s fading memory of how her mother applied baby powder every morning for thirty years. If this evidence is not documented — through recorded statements, written recollections, and attorney interviews — within the first weeks and months of opening a case, it may be gone forever.
Moderate urgency — expert causation analysis. The published science is durable — epidemiological studies do not disappear. But the expert report that bridges general causation to specific causation requires months of preparation. The expert must review the complete medical record, the exposure history, the pathology reports, the tumor characteristics, and the alternative-cause analysis. Daubert challenges must be anticipated. Every month of delay is a month the defense uses to prepare its own experts and its own Daubert motions. Expert report preparation should begin immediately.
Low urgency — medical and pathology records. Medical records are retained long-term by providers, typically for years or decades. But expert review of those records should begin immediately, because the records must be analyzed for cancer type, staging, treatment history, tumor histology, genetic testing results (BRCA status if tested), and imaging. These details anchor the specific-causation expert testimony and screen for confounders — alternative causes that the defense will exploit.
Low urgency — J&J internal corporate documents. The extensive public record of internal J&J documents produced in nationwide talc litigation — safety testing results, asbestos contamination findings, marketing and labeling decisions, internal communications about cancer risk studies — is accessible through discovery. These documents establish knowledge, notice, and the punitive damages predicate of conscious concealment or reckless disregard for consumer safety. They have been produced in prior cases and can be cataloged for the retrial record. The process is time-intensive but the documents themselves are not perishable.
Low urgency — original trial transcript and appellate decision. Court records are permanent. The trial transcript shows exactly what the defense presented, how the jury instructions were framed, and what evidentiary rulings shaped the first trial. The appellate decision defines what the defense cannot rely upon on retrial and shapes the evidentiary strategy for both sides. Trial counsel must analyze the sufficiency ruling immediately to build the retrial framework.
The Proof Story: How a Talc Cancer Case Is Built
Here is how a case like this is actually built, from the day a family calls to the day a jury hears it:
Week one: the preservation letter. The first document that goes out is a litigation-hold and spoliation-preservation demand. It goes to every entity in the corporate chain — Johnson & Johnson, Johnson & Johnson Consumer Inc., and any other entity that may have held relevant documents. It demands preservation of all internal communications, safety testing data, asbestos contamination findings, marketing decisions, labeling changes, and regulatory correspondence related to talc-based products. This letter creates a legal obligation: if J&J destroys documents after receiving it, the jury can be told to assume the destroyed evidence was as damaging as the plaintiff claims.
Weeks one through four: the family interview. We sit down with every surviving family member who observed the decedent’s daily routines. We document — in recorded statements and written recollections — the specific product, the frequency of use, the duration of use, the method of application, and the location of application. We collect any surviving product containers, receipts, or household items that corroborate the usage history. This is the evidence no appellate ruling can regenerate, and it is the foundation of specific causation.
Months one through three: medical record review and expert retention. We obtain the complete medical record — pathology reports, imaging, treatment history, genetic testing results, operative reports, biopsy results. We retain a board-certified gynecologic oncologist or cancer epidemiologist to anchor general causation. We retain a forensic pathologist or toxicologist with exposure-reconstruction expertise to bridge to specific causation. The experts review the records, the exposure history, and the literature, and they begin preparing their reports.
Months three through six: discovery and the document war. We serve discovery on J&J — interrogatories, document requests, and requests for admission. We demand production of the internal corporate documents that have been generated in prior talc litigation: safety testing memos, asbestos contamination findings, internal communications about cancer risk studies, marketing and labeling decisions, and any documents reflecting the company’s knowledge of the epidemiological literature. The defense will object, narrow, and delay. We push through.
Months six through twelve: depositions and Daubert preparation. We depose J&J’s corporate witnesses — the safety officers, the marketing executives, the regulatory affairs personnel, the scientists who conducted or reviewed the talc testing. We lock in their testimony about what the company knew and when. We prepare for the Daubert hearing — briefing the reliability of our experts’ methodology and challenging the defense experts’ methodology.
The retrial. In opening statement, the appellate ruling is woven in: a panel of judges on the Georgia Court of Appeals has already ruled that the defense evidence in the first trial was legally insufficient. The causation case is front-loaded. The family’s testimony about the decedent’s talc use is presented early and vividly. The internal corporate documents are introduced through the depositions of the people who wrote them. The defense’s alternative-cause arguments are met with the differential diagnosis. And in closing, the jury is asked to do what the first jury did not: hold a multibillion-dollar company accountable for selling a product it knew was associated with cancer risk and choosing not to warn the women who used it every day.
The First 72 Hours: What to Do Now
If you are reading this page because someone in your family died of cancer and you believe talc may have been the cause, here is what you should do — and what you should not do — in the first days:
Do document everything you remember. Write down what you know about the decedent’s talc use. What brand? How often? For how many years? Where was it applied? Who bought it? Where was it stored? When did she stop using it? Do this now, while your memory is fresh. Do not wait — memories fade, and the specifics matter more than you think.
Do collect any surviving product containers. If there are still bottles or containers of talc-based baby powder in the decedent’s home, do not throw them away. They are physical evidence. Photograph them in place, then store them safely. The product name, lot number, and packaging can connect the decedent’s exposure to a specific manufacturer and time period.
Do gather the medical records. Obtain the complete medical file — the pathology report that identified the cancer type, the imaging, the treatment records, the genetic testing results if any were done, and the death certificate. These records are the medical spine of the case.
Do talk to other family members. Ask siblings, children, and close friends what they remember about the decedent’s powder use. Record their recollections or ask them to write them down. Each person’s memory is a piece of the exposure history, and together they build the dose and duration that the specific-causation expert will rely on.
Do not sign anything from J&J or any insurance company. If you receive a letter, a phone call, or a visit from anyone representing Johnson & Johnson, its subsidiaries, or any insurance company, do not speak with them and do not sign anything. Anything you say can and will be used to undermine your case. Anything you sign may extinguish your rights.
Do not post about this on social media. The defense monitors social media. Posts about the decedent, her cancer, her product use, or your thoughts about the case can be taken out of context and used against you.
Do call a lawyer. The single most important step is to talk to a wrongful death claim lawyer who understands product liability litigation and the specific science of talc-related cancer. The call is free. The consultation is confidential. And the day you call is the day the evidence-preservation clock starts working for you instead of against you.
Who May Be Eligible: Long-Term Perineal Talc Users Who Developed Cancer
If you or a family member used talc-based baby powder in the perineal region — the area between the vagina and the anus — regularly for years or decades, and then developed ovarian cancer, endometrial cancer, or mesothelioma, you may have a claim. The strength of the claim depends on:
- The duration and frequency of talc use
- The specific product and brand used
- Whether the cancer type is one that has been associated with talc exposure in the scientific literature
- Whether alternative causes (genetic predisposition, BRCA mutations, family history) have been ruled out
- Whether the claim is within Georgia’s statute of limitations, considering the discovery rule for toxic exposure cases
If the person who used the talc has died, the claim belongs to the surviving family under Georgia’s wrongful death statute and to the estate under the survival action. A personal representative must be appointed to bring the case — and we handle that appointment as part of the process.
Frequently Asked Questions
What does it mean that the appellate court said the defense verdict was “not supported by sufficient evidence”?
It means that the evidence Johnson & Johnson presented to support the jury’s verdict in its favor was legally inadequate. The trial judge granted a new trial, and the Georgia Court of Appeals agreed. The case will be retried before a new jury. It does not mean the plaintiff won — but it means the defense’s evidentiary case was adjudicated as falling short of what the law requires, which is a powerful tool for the retrial.
How long do I have to file a talc cancer wrongful death claim in Georgia?
Georgia’s wrongful death statute of limitations is generally two years from the date of death. However, in toxic exposure cases, the discovery rule may affect when the clock starts — it may not begin until the family knew or reasonably should have known that the cancer was connected to talc use. This is a fact-specific question that must be evaluated by a Georgia attorney. Do not assume the deadline has passed without checking.
Can I still file a claim if my loved one died years ago?
It depends on when you learned or should have learned about the connection between talc and cancer. For many families, that connection was never made until years after the death. The discovery rule in toxic exposure cases may extend the filing window. You need to speak with a lawyer to evaluate your specific timeline.
Does Georgia cap damages in product liability cases?
Georgia generally caps punitive damages, but it expressly exempts product liability actions from that cap. This means a jury in a talc cancer case can return a punitive damages award without a statutory ceiling — a significant difference from many other states. Non-economic damages in wrongful death (the intangible value of the life) are not subject to a medical-malpractice-style cap in the product liability context.
What if the person who used the talc is still alive but has cancer?
If the person is still alive, the claim is a personal injury claim rather than a wrongful death claim. The damages include past and future medical expenses, lost wages and earning capacity, pain and suffering, and potentially punitive damages. The statute of limitations for a personal injury claim in Georgia is generally two years from the date of injury — but in a toxic exposure case, the discovery rule may mean the clock starts when the person discovered or should have discovered the connection between the cancer and talc use.
How much does it cost to hire a lawyer for a talc cancer case?
We handle these cases on contingency. The fee is 33.33 percent of the recovery before trial and 40 percent if the case goes to trial. We do not get paid unless we win your case. The first consultation is free and confidential.
What if I don’t have receipts or proof of purchase for the talc products?
Receipts are helpful but not essential. The strongest evidence of product use is often family testimony — the recollections of people who observed the decedent’s daily routines over years or decades. What brand she used, how often she used it, where she applied it, and for how many years are facts that live in the memories of the people who knew her. This is why documenting those memories early is the most important evidence-preservation step.
Is it too late to join the J&J talc litigation?
More than 68,000 talc claims are pending against Johnson & Johnson in the federal MDL, and individual cases are being filed in state courts across the country, including in Georgia. The deadline to file depends on your state’s statute of limitations and the discovery rule. It may not be too late — but you will not know until you ask.
Will J&J try to use bankruptcy to avoid my claim?
J&J has tried three times to push talc liability into a bankruptcy vehicle, and all three attempts have been dismissed by federal courts. The most recent dismissal came on March 31, 2025, when the U.S. Bankruptcy Court for the Southern District of Texas threw out Red River Talc LLC’s prepackaged Chapter 11. The cases are back in the tort system. J&J may try again, but the track record of dismissals is strong evidence that courts will not allow the maneuver.
What makes Attorney911 different from other firms handling talc cases?
Our firm brings something most plaintiff firms cannot: Lupe Peña spent years inside a national insurance-defense firm — the rooms where claims are valued, delayed, and denied — before choosing to use that knowledge for injured clients. He knows how the other side thinks because he was the other side. Ralph Manginello has 27-plus years of trial experience, including federal court, and was a journalist before he was a lawyer — which means he knows how to build a story a jury can follow, not just a legal brief a judge can read. Together, they bring the insider’s knowledge of how defendants value claims and the trial lawyer’s skill to actually take a case to verdict. We serve families in English and in Spanish. Hablamos Español.
Why Attorney911
We are Attorney911 — The Manginello Law Firm, PLLC. We are a trial firm that takes Georgia cases, working with local counsel and pro hac vice admission where required. We do not claim an office in Georgia, and we will not pretend to have a Georgia bar number we do not hold. What we do have is 27-plus years of courtroom experience, a former insurance-defense attorney who knows how the other side prices and defends claims, and a track record of recovering millions for injured clients.
Ralph P. Manginello is our Managing Partner. He has been licensed since November 6, 1998 — 27-plus years of trial practice. He is admitted to the U.S. District Court, Southern District of Texas, and has tried cases in both state and federal court. He was a journalist before he was a lawyer, which means he builds cases as stories — stories a jury can see, feel, and remember. He speaks Spanish.
Lupe Peña is our associate attorney. He is a former insurance-defense attorney who spent years at a national defense firm — the rooms where adjusters and their software decide how to deny, delay, and devalue claims. He knows how the defense values a case from the inside: how reserves are set, how IME doctors are selected, how surveillance is used, how recorded statements are engineered. Now he sits on your side of the table. He conducts full consultations in Spanish without an interpreter.
Our fee is contingency. 33.33 percent before trial. 40 percent if the case goes to trial. We do not get paid unless we win your case. The first consultation is free. The call is confidential. And our line is staffed 24 hours a day, 7 days a week — not by an answering service, but by live people who can connect you to a lawyer.
Call us at 1-888-ATTY-911 (1-888-288-9911). Or email Ralph at ralph@atty911.com or Lupe at lupe@atty911.com. Contact us through our website any time.
If you are not sure whether you have a case, call and ask. If we are not the right fit for your situation, we will tell you. But if your family lost someone to cancer after decades of talc use, and you want to know whether the law can hold the company that sold that powder accountable — we can answer that question. And the answer might change everything you thought you knew about what happened.
Past results depend on the facts of each case and do not guarantee future outcomes. This page is legal information, not legal advice. Contacting the firm is free and confidential. Hablamos Español.